Cannabidiol for the treatment of psychosis in Parkinson's disease (2009)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.1177/0269881108096519
- Subjects: DOENÇA DE PARKINSON (TRATAMENTO); TRANSTORNOS PSICÓTICOS (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Psychopharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 23, n.8, p. 979-983, 2009
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZUARDI, Antonio Waldo et al. Cannabidiol for the treatment of psychosis in Parkinson's disease. Journal of Psychopharmacology, v. 23, n. 8, p. 979-983, 2009Tradução . . Disponível em: https://doi.org/10.1177/0269881108096519. Acesso em: 10 fev. 2026. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Pinto, J. P., Chagas, M. H. N., Rodrigues, G. G. R., et al. (2009). Cannabidiol for the treatment of psychosis in Parkinson's disease. Journal of Psychopharmacology, 23( 8), 979-983. doi:10.1177/0269881108096519 -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Pinto JP, Chagas MHN, Rodrigues GGR, Dursun SM, Tumas V. Cannabidiol for the treatment of psychosis in Parkinson's disease [Internet]. Journal of Psychopharmacology. 2009 ; 23( 8): 979-983.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1177/0269881108096519 -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Pinto JP, Chagas MHN, Rodrigues GGR, Dursun SM, Tumas V. Cannabidiol for the treatment of psychosis in Parkinson's disease [Internet]. Journal of Psychopharmacology. 2009 ; 23( 8): 979-983.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1177/0269881108096519 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
Informações sobre o DOI: 10.1177/0269881108096519 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
